Analysis Ascelia Pharma: Enhancing value
19 Jun 2019
Ascelia has filed a patent application for a more user friendly formulation for the contrast agent Mangoral. If approved, the patent extends to 2040. Prospects for a longer market exclusivity leads us to increase fair value.
Read the full report (Swedish) here.